Last reviewed · How we verify
NCT03339466
Inspiratory Muscle Therapy in Subjects With Fontan Circulations
NA trial testing Inspiratory muscle therapy in Single-ventricle in 7 participants. Completed in 31 August 2017.
24 August 2016
Quick facts
| Lead sponsor | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 29 January 2016 |
| Primary completion | 24 August 2016 |
| Estimated completion | 31 August 2017 |
Drugs / interventions tested
- Inspiratory muscle therapy
Conditions studied
- Single-ventricle — all drugs for Single-ventricle →
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Who can join
Adults 18 to 80, any sex, with Single-ventricle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Individuals who have undergone the Fontan procedure are uniquely dependent upon respiratory mechanics to support pulmonary blood flow (PBF). The investigators hypothesized that enhanced respiratory muscle function via inspiratory muscle training (IMT) would improve performance on cardiopulmonary exercise stress testing (CPET).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03339466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Single-ventricle
Currently open trials in the same condition.
- NCT07073612 — Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity · recruiting
- NCT06434207 — Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis · recruiting
- NCT06613477 — PK/PD of Digoxin in Infants With SVHD · Phase 1, PHASE2 · recruiting
- NCT06538571 — Association of Near Infrared Spectroscopy With Interstage Outcomes · NA · recruiting
- NCT06150950 — REHAB Fontan Failure: A Trial of Cardiac Rehabilitation · NA · recruiting
Other Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center trials
Trials by the same sponsor.
- NCT04526860 — Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity · NA · withdrawn
- NCT02720874 — Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis · NA · withdrawn
- NCT04918719 — Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke · Phase 2 · completed
- NCT06342609 — Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease · Phase 4 · completed
- NCT05398692 — Long COVID-19 Rehabilitation & Recovery Research Program · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03339466 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Last refreshed: 29 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03339466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing